New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareRetatrutide vs Oxytocin

Retatrutide vs Oxytocin

Side-by-side comparison of key properties, dosing, and research.

GLP-1 / Weight Loss Agonists
Retatrutide
Cognitive EnhancementSexual Health & Libido
Oxytocin
Summary
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 trials showed an unprecedented average 24% body weight reduction at 48 weeks — exceeding any approved medication to date. It is in Phase 3 trials as of 2024.
Oxytocin is a 9-amino acid neuropeptide produced in the hypothalamus with diverse roles in social bonding, trust, stress reduction, and sexual function. Exogenous administration is used therapeutically to improve social cognition, reduce anxiety, and enhance intimacy.
Half-Life
~10–12 days
~3–5 minutes (IV); ~30–60 minutes (intranasal, CNS effects persist longer)
Admin Route
SubQ
Intranasal, SubQ, IV
Research
Typical Dose
0.5 mg → 1 mg → 2 mg → 4 mg → 8 mg → 12 mg
20–40 IU
Frequency
Once weekly
As needed (not daily long-term)
Key Benefits
  • ~24% body weight reduction at 48 weeks in Phase 2 (highest dose)
  • Superior to both semaglutide and tirzepatide in early trial comparisons
  • Triple receptor mechanism addresses multiple obesity pathways
  • Significant reduction in liver fat (MASH/NAFLD indication being studied)
  • Improved cardiovascular and metabolic markers
  • Once-weekly dosing
  • Potential for greatest weight loss of any currently investigated compound
  • Enhances social bonding and trust
  • Reduces social anxiety and fear of rejection
  • Improves autism spectrum symptoms (social cognition)
  • Reduces cortisol and stress reactivity
  • Enhances sexual arousal and intimacy
  • Promotes maternal behavior and bonding
  • May improve depressive symptoms
  • Appetite suppression and metabolic effects
Side Effects
  • Nausea and vomiting (common during titration, similar to semaglutide/tirzepatide)
  • Diarrhea
  • Constipation
  • Heart rate increase (from glucagon receptor agonism)
  • +2 more
  • Mild uterine cramping (avoid in pregnancy)
  • Nasal irritation (intranasal)
  • Headache
  • Potential emotional over-attachment or jealousy amplification
  • +2 more
Stacks With